MDxHealth (MDXH) Capital Expenditures (2021 - 2026)

MDxHealth has reported Capital Expenditures for 5 years, with the latest figure at -$362000.0 in Q1 2026.

• Quarterly Capital Expenditures rose 23.95% year-over-year to -$362000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 343.73% YoY) and the FY2025 annual result came in at $1.2 million, down 2.61% from the prior year.
• Capital Expenditures grew to -$362000.0 in Q1 2026 per MDXH's latest filing, from -$1.1 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $2.2 million in Q4 2024 and troughed at -$1.1 million in Q3 2025.
• A 4-year average of -$216500.0 and a median of -$419000.0 in 2025 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2025 and 2026: Capital Expenditures sank 425.24% in 2025, then grew 23.95% in 2026.
• Over 4 years, Capital Expenditures stood at -$357000.0 in 2022, then jumped by 711.76% to $2.2 million in 2024, then tumbled by 150.5% to -$1.1 million in 2025, then soared by 67.18% to -$362000.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered -$362000.0, -$1.1 million, and -$840000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.